131 related articles for article (PubMed ID: 2164377)
1. Experimental reactivation of bovine herpesvirus 1 (BHV-1) by means of corticosteroids in an intranasal rabbit model.
Brown GA; Field HJ
Arch Virol; 1990; 112(1-2):81-101. PubMed ID: 2164377
[TBL] [Abstract][Full Text] [Related]
2. Thymidine kinase-negative bovine herpesvirus type 1 mutant is stable and highly attenuated in calves.
Kit S; Qavi H; Gaines JD; Billingsley P; McConnell S
Arch Virol; 1985; 86(1-2):63-83. PubMed ID: 2994602
[TBL] [Abstract][Full Text] [Related]
3. The pathogenesis of wild type and drug resistant mutant strains of bovine herpesvirus-1 (BHV-1) in the natural host.
Gilliam SE; Thackray AM; Brown GA; Field HJ
Arch Virol; 1993; 128(1-2):43-54. PubMed ID: 8380324
[TBL] [Abstract][Full Text] [Related]
4. A mutation in the latency-related gene of bovine herpesvirus 1 disrupts the latency reactivation cycle in calves.
Inman M; Lovato L; Doster A; Jones C
J Virol; 2002 Jul; 76(13):6771-9. PubMed ID: 12050390
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone-induced reactivation of bovine herpesvirus type 5 latent infection in experimentally infected rabbits results in a broader distribution of latent viral DNA in the brain.
Mayer SV; Quadros VL; Vogel FS; Winkelmann ER; Arenhart S; Weiblen R; Flores EF
Braz J Med Biol Res; 2006 Mar; 39(3):335-43. PubMed ID: 16501813
[TBL] [Abstract][Full Text] [Related]
6. Detection of latent thymidine kinase-deficient herpes simplex virus in trigeminal ganglia of mice using the polymerase chain reaction.
Friedrich A; Kleim JP; Schneweis KE
Arch Virol; 1990; 113(1-2):107-13. PubMed ID: 2167055
[TBL] [Abstract][Full Text] [Related]
7. Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies.
Lemaire M; Schynts F; Meyer G; Georgin JP; Baranowski E; Gabriel A; Ros C; Belák S; Thiry E
Vaccine; 2001 Sep; 19(32):4795-804. PubMed ID: 11535332
[TBL] [Abstract][Full Text] [Related]
8. Primary infection, latency, and reactivation of bovine herpesvirus type 5 in the bovine nervous system.
Perez SE; Bretschneider G; Leunda MR; Osorio EA; Flores EF; Odeón AC
Vet Pathol; 2002 Jul; 39(4):437-44. PubMed ID: 12126146
[TBL] [Abstract][Full Text] [Related]
9. The weakly virulent herpes simplex virus type 1 strain KOS-63 establishes peripheral and central nervous system latency following intranasal infection of rabbits, but poorly reactivates in vivo.
Stroop WG; Banks MC
J Neuropathol Exp Neurol; 1992 Sep; 51(5):550-9. PubMed ID: 1325537
[TBL] [Abstract][Full Text] [Related]
10. A gene capable of blocking apoptosis can substitute for the herpes simplex virus type 1 latency-associated transcript gene and restore wild-type reactivation levels.
Perng GC; Maguen B; Jin L; Mott KR; Osorio N; Slanina SM; Yukht A; Ghiasi H; Nesburn AB; Inman M; Henderson G; Jones C; Wechsler SL
J Virol; 2002 Feb; 76(3):1224-35. PubMed ID: 11773398
[TBL] [Abstract][Full Text] [Related]
11. Recovery of a latent HSV-1 thymidine kinase negative strain following iontophoresis and co-cultivation in the ocularly-infected rabbit model.
Caudill JW; Romanowski E; Araullo-Cruz T; Gordon YJ
Curr Eye Res; 1986 Jan; 5(1):41-5. PubMed ID: 3007031
[TBL] [Abstract][Full Text] [Related]
12. Analysis of latency in cattle after inoculation with a temperature sensitive mutant of bovine herpesvirus 1 (RLB106).
Jones C; Newby TJ; Holt T; Doster A; Stone M; Ciacci-Zanella J; Webster CJ; Jackwood MW
Vaccine; 2000 Jul; 18(27):3185-95. PubMed ID: 10856798
[TBL] [Abstract][Full Text] [Related]
13. Analysis by RNA-PCR of latency and reactivation of herpes simplex virus in multiple neuronal tissues.
Tanaka S; Minagawa H; Toh Y; Liu Y; Mori R
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2691-8. PubMed ID: 7931155
[TBL] [Abstract][Full Text] [Related]
14. DNA of bovine herpesvirus type 1 in the trigeminal ganglia of latently infected calves.
Ackermann M; Peterhans E; Wyler R
Am J Vet Res; 1982 Jan; 43(1):36-40. PubMed ID: 6283952
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
[TBL] [Abstract][Full Text] [Related]
16. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis.
Efstathiou S; Kemp S; Darby G; Minson AC
J Gen Virol; 1989 Apr; 70 ( Pt 4)():869-79. PubMed ID: 2543763
[TBL] [Abstract][Full Text] [Related]
17. Latency of a thymidine kinase-negative pseudorabies vaccine virus detected by the polymerase chain reaction.
Volz DM; Lager KM; Mengeling WL
Arch Virol; 1992; 122(3-4):341-8. PubMed ID: 1309996
[TBL] [Abstract][Full Text] [Related]
18. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.
Coen DM; Kosz-Vnenchak M; Jacobson JG; Leib DA; Bogard CL; Schaffer PA; Tyler KL; Knipe DM
Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4736-40. PubMed ID: 2543985
[TBL] [Abstract][Full Text] [Related]
19. A low thymidine kinase-producing mutant of herpes simplex virus type 1 causes latent trigeminal ganglia infections in mice.
Gordon Y; Gilden DH; Shtram Y; Asher Y; Tabor E; Wellish M; Devlin M; Snipper D; Hadar J; Becker Y
Arch Virol; 1983; 76(1):39-49. PubMed ID: 6305312
[TBL] [Abstract][Full Text] [Related]
20. Neuronal control of herpes simplex virus latency.
Tenser RB; Edris WA; Hay KA
Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
